Written question asked by Peter Prinsley (Labour) on Thursday, 16 July 2026, in the House of Commons. It was due for an answer on Wednesday, 2 September 2026. It was answered by Diana Johnson (Labour) on Thursday, 3 September 2026 on behalf of the Department of Health and Social Care.

Prostate Cancer: Screening

Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 July 2026 to Question 11285, and with reference to the report entitled UK National Screening Committee, Screening for prostate cancer, whether his Department is taking steps to estimate the cost of identifying new BRCA2 variant carriers.

Answer: The Department estimates that there are approximately 1,500 men currently known to have both a BRCA2 gene variant and a family history of breast, pancreatic, ovarian, or prostate cancer who will be eligible for the targeted prostate cancer screening programme. The Department has not estimated the costs of identifying additional BRCA2 variant carriers, as the UK National Screening Committee, which advises the Government on all screening related matters, did not recommend proactively identifying BRCA2 carriers.

Secondary information

Type: Written question
Reference: 19612
Session: 2026-27
Related items: Prostate Cancer: Screening
Thursday, 9 July 2026
Written questions
House of Commons
Subjects: Costs Genetics Prostate cancer Screening
Link: View this Written question on www.parliament.uk